High Point Advisor Group LLC Dexcom Inc Transaction History

High Point Advisor Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$110.31 - $140.45 $19,083 - $24,297	-173 Reduced 4.78%	3,448 $390,000
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $1,713 - $2,101	15 Added 0.42%	3,621 $502,000
Q4 2023 Mar 26, 2024	BUY	$75.49 - $124.16 $9,511 - $15,644	126 Added 3.62%	3,606 $447,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $186,156 - $363,852	2,738 Added 369.0%	3,480 $263,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $5,015 - $6,729	47 Added 6.76%	742 $406,000
Q2 2021 Jul 29, 2021	BUY	$80.99 - $107.93 $10,447 - $13,922	129 Added 22.79%	695 $297,000
Q4 2020 Feb 10, 2021	SELL	$78.0 - $104.5 $119,496 - $160,094	-1,532 Reduced 73.02%	566 $227,000
Q3 2020 Nov 06, 2020	BUY	$95.51 - $112.95 $14,230 - $16,829	149 Added 7.64%	2,098 $745,000
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $4,951 - $8,321	-79 Reduced 3.9%	1,949 $780,000
Q1 2020 May 01, 2020	BUY	$47.79 - $75.63 $64,707 - $102,403	1,354 Added 200.89%	2,028 $674,000
Q1 2020 Apr 27, 2020	BUY	$47.79 - $75.63 $32,210 - $50,974	674 New	674 $2.03 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.